Celldex Therapeutics (CLDX) Non Operating Income (2010 - 2012)
Celldex Therapeutics' (CLDX) quarterly Non Operating Income came in at $105000.0 in Q3 2012, down 27.08% year-on-year from $144000.0 in Q4 2011, and down 16.67% quarter-over-quarter from $126000.0 in Q2 2012.
Celldex Therapeutics (CLDX) Non Operating Income (2010 - 2012) Analysis & Trends
Celldex Therapeutics' Non Operating Income history runs 3 years deep, the most recent figure standing at $105000.0 for Q3 2012.
- On a quarterly basis, Non Operating Income fell 27.08% year-over-year to $105000.0 in Q3 2012; TTM through Sep 2012 was $525000.0, a 75.99% decrease from a year earlier, with the FY2011 full-year figure at $396000.0, down 92.47% from the prior year.
- Non Operating Income eased to $105000.0 in Q3 2012 per CLDX's latest filing, from $126000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $1.9 million in Q4 2010 and bottomed at $79000.0 in Q2 2011.
- The 3-year median for Non Operating Income is $114500.0 (2010), against an average of $293100.0.
- Across the five-year window, Non Operating Income slumped 95.27% in 2011 and surged 144.05% in 2012, its largest moves.
- Year by year, Non Operating Income stood at $1.9 million in 2010, then slumped by 95.27% to $89000.0 in 2011, then increased by 17.98% to $105000.0 in 2012.
- Per Business Quant, the three latest CLDX Non Operating Income figures stand at $105000.0 (Q3 2012), $126000.0 (Q2 2012), and $205000.0 (Q1 2012).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Celldex Therapeutics | 1.72 Mn | 1.72 Mn | -1.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2012 | 105,000.00 |
| Jun 30, 2012 | 126,000.00 |
| Mar 31, 2012 | 205,000.00 |
| Dec 31, 2011 | 89,000.00 |
| Sep 30, 2011 | 144,000.00 |
| Jun 30, 2011 | 79,000.00 |
| Mar 31, 2011 | 84,000.00 |
| Dec 31, 2010 | 1.88 Mn |
| Sep 30, 2010 | 124,000.00 |
| Jun 30, 2010 | 95,000.00 |